Ames-based NewLink Genetics Corp. announced Thursday it has been awarded an $18 million contract option for its Ebola vaccine candidate.
The contract is with the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services. The pharmaceutical company Merck &Co. has the license for research, development, manufacturing and commercialization of the vaccine, according to a press release.
